Rockville, MD Attorney News Archive

Authorities in Montgomery County, Maryland, responded swiftly to a report of a shooter at the Walter Reed National Military Medical Center. The situation prompted an investigation into an individual found with a toy rifle, raising temporary concerns in the nearby Virginia area among local officials and law enforcement.

Captain Jared M. Tate of the Montgomery County Department of Police confirmed that the individual involved had no malicious intent and would not face any criminal defense charges. This prompt resolution brought relief to local residents, as it ensured that there were no disruptions to employment or threats to safety in the community.

This incident highlights the crucial role of civil procedures and the importance of vigilance and clear communication in maintaining safety in public spaces.

Sarepta Therapeutics is under intense scrutiny following the unfortunate death of a second patient who received its Elevidys gene therapy for Duchenne muscular dystrophy (DMD). The FDA is actively monitoring the situation, responding to concerns regarding acute liver failure associated with the therapy, particularly for non-ambulatory patients.

In light of these developments, Louise Rodino-Klapac, Sarepta's Chief Scientific Officer, affirmed the company’s dedication to patient safety. She announced a halt on Elevidys shipments for non-ambulatory individuals while the company conducts a thorough investigation.

The situation has raised alarms among legal and corporate analysts, including Kostas Biliouris from BMO Capital Markets in Chicago. Analysts are wary of possible regulatory changes under new FDA leadership. Furthermore, the ongoing civil litigation concerning Elevidys highlights critical issues about the future of this contentious treatment and emphasizes calls for increased oversight in the realms of business, corporate governance, and IP and technology law.